Javier J. Rodriguez

Chief Executive Officer at DaVita Inc

Since June 2019

Age

53 years

Tenure

Joined DVA in 1998 and held various leadership roles including Director of Value Management, Vice President of Operations and Payor Contracting (2000-2006), Senior Vice President (2006-2012), President (2012-2014), and CEO of DaVita Kidney Care (2014-2019) before becoming CEO in June 2019.

Also at DaVita Inc

Christopher Berry

Chief Accounting Officer

DPM

David P. Maughan

Chief Operating Officer, Kidney Care

JOH

James O. Hearty

Chief Compliance Officer

About

Javier J. Rodriguez is currently 53 years old and has built a distinguished career at DaVita Inc. He began his journey in 1998 as the Director of Value Management, steadily progressing through various leadership roles over the years.

Throughout his tenure, he has contributed significantly to the company, holding key positions such as Vice President of Operations and Payor Contracting (2000-2006), Senior Vice President (2006-2012), and President (2012-2014). He then led DaVita Kidney Care as CEO from 2014 to 2019 before stepping into his current role as CEO of DaVita Inc. in June 2019.

In addition to his responsibilities at DaVita, he extends his leadership to the broader healthcare industry by serving on the Board of Directors of Gilead Sciences, Inc. since June 2020. While his professional contributions are well documented, details regarding his educational background and personal life remain undisclosed in the available information.

$DVA Performance Under Javier J. Rodriguez

Past Roles

Organization	Role	Date Range	Details
DaVita Inc.	CEO of DaVita Kidney Care	March 2014 - June 2019	Former role; preceded his current role as CEO of DaVita Inc.
DaVita Inc.	President	February 2012 - March 2014	Former role at DaVita Inc.
DaVita Inc.	Senior Vice President	April 2006 - February 2012	Former role at DaVita Inc.
DaVita Inc.	Vice President of Operations and Payor Contracting	2000 - 2006	Former role at DaVita Inc.
DaVita Inc.	Director of Value Management	Joined in 1998	Former role at DaVita Inc.
Baxter Healthcare Corporation	Finance Department Role	1995 - 1996	Previous position held before joining DaVita Inc.
CBS Marketing Inc.	Director of Operations	N/A	Based in Mexico City

External Roles

Organization	Role	Date Range	Details
Gilead Sciences, Inc.	Member of the Board of Directors	June 2020 - Present	Research-based pharmaceutical company

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$1,500,000	Annual	Increased by 25% from 2022 to align with competitive market
Other Personal Benefits	$1,092,397	Annual	Covers security program and limited personal use of corporate aircraft
Life Insurance Premiums	$576	Annual	Premiums paid for life insurance coverage
Company Contribution to Defined Contribution Plan	$3,600	Annual	Contribution made to defined contribution plan

Performance Compensation

Data from FY 2023

Performance Metrics and Results for 2023

Metric	Weight (%)	Criteria Range	Target	Actual Performance	Eligible Payout Achieved
Adjusted Operating Income	50.0	$1,375M to $1,650M	$1,500M	$1,709M	200.0%
Free Cash Flow	20.0	$650M to $925M	$775M	$1,236M	200.0%
Home Modalities Penetration	7.5	15.25% to 17.00%	16.00%	15.47%	47.0%
CKCC Patient Contact Composite	7.5	20.0% to 55.0%	45.0%	54.8%	198.0%
Teammate Engagement	3.0	74.0% to 82.0%	78.0%	80.2%	155.0%
Water Savings Projects	3.0	25M to 75M gallons	50M gallons	100M gallons	200.0%
Individual Objectives	9.0	Varies by NEO	N/A	N/A	200.0%

Overall Summary

Description	Amount/Value	Details
Target Incentive Opportunity	$2,250,000	Set at 150% of the base salary
Total STI Program Award	$4,208,063	Achieved at 187.0% of target
Plan Type	Cash-Based	No vesting schedule, grant dates, fair value, or stock price associated

The evaluation period encompassed the full 2023 year with performance measured against both financial and strategic objectives. Actual results on key metrics resulted in payouts as detailed above.